Bernard N. Stulberg

Preoperative nutritional status of total joint patients: Relationship to postoperative wound complications

Abstract The records of 217 consecutive patients who underwent a primary total hip or total knee arthroplasty were reviewed for preoperative and post-operative nutritional status. Fifty-seven patients had a lymphocyte count of less than 1,500 cells/mm 3 , four patients had an albumin level of less than 3.5 g/dL, and two patients had both, giving a 27% incidence of indices indicative of preoperative nutritional depletion. Patients without wound complications had an average preoperative lymphocyte count of 1,995 (±631), compared to 1,638 (±491) for those with persistent serous drainage from their wounds, and 1,553 (±419) for those patients with a major wound complication ( P =.002). The average albumin levels were 4.30 (±0.33), 4.22 (±0.31), and 4.13 (±0.54), respectively. Patients with rheumatoid arthritis were compared to those with osteoarthritis and were found to have significantly lower preoperative albumin levels. They were three times as likely to develop a major wound complication. Patients on immunosuppressive medications had significantly lower preoperative lymphocyte counts, lower albumin levels, and higher complication rates ( P =.04). After operation, lymphocyte counts of all patients dropped to an average of 57% of their preoperative values, and albumin levels dropped to 72% of their preoperative values. No nutritional parameters had returned to their preoperative levels by 10 postoperative days. For all patients, a preoperative lymphocyte count of less than 1,500 cells/mm 3 was associated with a five times greater frequency of developing a major wound complication, and an albumin level of less than 3.5 g/dL had a seven times greater frequency. In the two patients with both low albumin levels and low lymphocyte counts, one suffered a deepwound infection, and the other a major dehiscence. Preoperative nutritional assessment to identify patients at risk for wound-healing complications following elective total hip and knee arthroplasty is warranted.

Prevention of Deep-Vein Thrombosis after Total Hip Arthroplasty. Comparison of Warfarin and Dalteparin*

The effectiveness and safety of warfarin were compared with those of a low-molecular-weight heparin (dalteparin) for the prevention of deep-vein thrombosis after total hip arthroplasty in a prospective, randomized, multi-institutional trial. Patients who were older than eighteen years of age and were scheduled to have an elective primary or revision total hip arthroplasty were eligible; 580 patients were randomized, 550 had the operation and received prophylaxis, and 382 had evaluable venograms. Prophylaxis was provided either with warfarin beginning the night before the operation or with dalteparin beginning two hours before the operation and was continued until venography was performed. Bleeding was assessed on the basis of intraoperative blood loss, transfusion requirements, a decrease in hematocrit, and clinically identified bleeding complications. The prevalence of deep-vein thrombosis was found to be significantly lower in the patients who had received dalteparin than in those who had received warfarin (twenty-eight [15 per cent] of 192 patients compared with forty-nine [26 per cent] of 190 patients; p = 0.006). Deep-vein thrombosis occurred in the calf veins of twenty-one patients (11 per cent) who had received dalteparin and of forty-three patients (23 per cent) who had received warfarin; this difference was significant (p = 0.003). Proximal deep-vein thrombosis occurred in ten patients (5 per cent) who had received dalteparin and in sixteen patients (8 per cent) who had received warfarin; however, with the numbers available, no significant difference could be detected (p = 0.185). We also could not detect a significant difference with regard to the intraoperative and postoperative blood loss, the decrease in hematocrit, and the prevalence of major bleeding complications between the two groups; however, the patients who had received dalteparin had a significantly higher prevalence of bleeding complications involving the operative site (p = 0.03), and a significantly greater percentage required postoperative transfusions (p = 0.001). We concluded that preoperative prophylaxis with dalteparin is significantly more effective than that with warfarin in preventing deep-vein thrombosis after total hip arthroplasty. The greater effectiveness of dalteparin must be considered, however, in light of an increased need for postoperative transfusions and an increase in the prevalence of wound-related bleeding complications.

Allograft reconstruction of the acetabulum during revision total hip arthroplasty. Clinical, radiographic, and scintigraphic assessment of the results.

In twenty-one hips of twenty-one patients, the acetabulum was reconstructed using allografts during revision of a total hip arthroplasty. The patients average age at the time of revision was 64.3 years (range, nineteen to eighty-six years). At an average follow-up of 3.5 years (range, two to five years), three patients had died of causes unrelated to the hip reconstruction, and one had been lost to follow-up. In the other seventeen, the average Harris hip rating was 89 points (range, seventy to 100 points) at follow-up. In one patient the allograft collapsed, so that revision was required. Two patients had asymptomatic progressive radiolucencies at the cement-bone interface of the reconstructed acetabulum, and another had a 1.5-millimeter-wide lucency at the interface of the donor and recipient bone but was asymptomatic, and there had been no change in the position of the cemented acetabular component since operation. The remaining grafts appeared to be incorporated securely, as determined by radiographic examination. Three-dimensional computerized tomographic radioisotopic bone scans showed uniform uptake, consistent with revascularization and new-bone formation, in all grafts. There was no radiographic evidence of focal avascularity and there were no infections. Femoral-head bone allografts appear to provide a useful technique for the reconstruction of a severely deficient acetabulum during revision total hip arthroplasty.

Characterization and comparison of wear debris from failed total hip implants of different types

Particles of wear debris have been associated with loosening of implants and with osteolysis, but few studies have examined the relationship between characteristics of the implant and clinical variables and the concentration of particles isolated from periarticular tissues. We isolated and quantified particles of wear debris from orthopaedic implants in 123 tissue samples that had been obtained adjacent to a failed total hip prosthesis from eighty-eight patients. The concentration of these particles in the tissue and the size of the particles were then analyzed in relation to patient and implant-related variables. The number of particles ranged from 8.5 x 108 to 5.7 x 1011 per gram of tissue (dry weight). More particles were found adjacent to failed titanium-alloy stems that had a cobalt-chromium-alloy modular head and failed titanium-alloy-backed cups than were found adjacent to all-cobalt-chromium-alloy prostheses. In addition, fewer particles were found adjacent to implants with a twenty-eight-millimeter femoral head than were found adjacent to implants with other femoral head sizes. Univariate analysis also showed correlations between a high concentration of particles and fixation without cement, an implant that had been in situ for a long duration, a young patient age, and an initial clinical diagnosis of avascular necrosis. Biopsy specimens from the proximal femoral membranes had higher concentrations than those from the joint capsules or the acetabular membranes. Although only five specimens were obtained directly from osteolytic lesions, the concentration of particles in those specimens was higher than that in biopsy specimens from other sites. Although many univariate correlations were identified, stepwise correlation regression analysis showed that the composition of the implant and the size of the modular femoral head were most strongly related to the concentration of debris in tissue. CLINICAL RELEVANCE: The results of this study show that most failed hip implants are associated with billions of debris particles and that the concentration of these particles in tissue is related to several factors that are thought to be associated with the extent of implant wear. There are probably many factors that influence the production of orthopaedic wear debris. Some are related to the design of the implant. Others, such as the level of activity, are related to the patient. Of the variables tested in this study, the composition of the implant and the size of the modular head appeared to be most closely linked with the production of particles. Our results do not necessarily reflect the extent of debris production by stable implants, but they suggest that the metallic composition of the femoral stem, the acetabular cup, and the modular head may have an important influence on the amount of wear debris.

Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease: Results of a multicenter study at a mean of three years after treatment

BACKGROUNDnOsteonecrosis of the femoral head is a common complication in patients with sickle cell disease, and collapse of the femoral head occurs in 90% of patients within five years after the diagnosis of the osteonecrosis. However, the efficacy of hip core decompression to prevent the progression of osteonecrosis in these patients is still controversial.nnnMETHODSnIn a prospective multicenter study, we evaluated the safety of hip core decompression and compared the results of decompression and physical therapy with those of physical therapy alone for the treatment of osteonecrosis of the femoral head in patients with sickle cell disease. Forty-six patients (forty-six hips) with sickle cell disease and Steinberg Stage-I, II, or III osteonecrosis of the femoral head were randomized to one of two treatment arms: (1) hip core decompression followed by a physical therapy program or (2) a physical therapy program alone. Eight patients withdrew from the study, leaving thirty-eight who participated.nnnRESULTSnSeventeen patients (seventeen hips) underwent decompression combined with physical therapy, and no intraoperative or immediate postoperative complications occurred. Twenty-one patients (twenty-one hips) were treated with physical therapy alone. After a mean of three years, the hip survival rate was 82% in the group treated with decompression and physical therapy and 86% in the group treated with physical therapy alone. According to a modification of the Harris hip score, the mean clinical improvement was 18.1 points for the patients treated with hip core decompression and physical therapy compared with 15.7 points for those treated with physical therapy alone. With the numbers studied, the differences were not significant.nnnCONCLUSIONSnIn this randomized prospective study, physical therapy alone appeared to be as effective as hip core decompression followed by physical therapy in improving hip function and postponing the need for additional surgical intervention at a mean of three years after treatment.

The incorporation of tibial allografts in total knee arthroplasty.

Twelve knees in ten patients had revision total knee replacement with insertion of an allograft for a large tibial defect. The knees were retrospectively evaluated at an average of thirty-two months (range, twenty-five to fifty-one months) by clinical examination, radiography, planar bone scintigraphy, and single-photon-emission computed tomography. The average age of the patients was sixty-two years (range, fifty-four to seventy-nine years). A constrained total-condylar prosthesis was used for all revisions. A contained tibial defect was present in five knees, and seven knees had an uncontained defect that was treated with a massive composite structural allograft, five of which were secured with internal fixation. The knee scores improved from an average of 51 points before operation to an average of 87 points post-operatively. Seven knees had a score of 85 points or more and were considered to have an excellent clinical result. Two knees had a good result, with scores of 77 and 72 points. One knee had another revision because of painful non-union of a medial structural graft, and the result in that knee was considered a failure. The average range of motion improved from 84 degrees to 105 degrees. There were no deep infections, and no graft showed evidence of fracture or collapse. Radiographs demonstrated complete incorporation of the graft in eleven of the twelve knees at an average of twenty-three months after operation. Single-photon-emission computed-tomography scans showed uniform activity in the area of the graft in four of the five knees that were studied.

Results and lessons learned from a United States hip resurfacing investigational device exemption trial.

BACKGROUNDnImprovements in metal-on-metal bearings have made hybrid hip surface replacement a potential alternative for the young active patient with end-stage hip disease. Possible advantages include greater hip joint stability, bone preservation, and decreased osteolysis. In this study, we compared the clinical and radiographic results of a new resurfacing device with those in a historical group of standard total hip arthroplasties.nnnMETHODSnIn 2001, the Cormet 2000 Hip Resurfacing Investigational Device Exemption study was initiated at twelve centers. A total of 337 patients treated with unilateral hip surface replacement with the Cormet device were enrolled in that study. These patients were compared with 266 patients in a previous study who had undergone unilateral total hip arthroplasty with ceramic bearing surfaces. Clinical and radiographic results were compared at similar time intervals. A newly recommended performance standard, the composite clinical success score, was used to assess non-inferiority of the hip resurfacing compared with the total hip arthroplasty used in the historical comparison population.nnnRESULTSnAt the time of follow-up, at a minimum of two years, the Harris hip scores were comparable between the resurfacing and total hip arthroplasty groups. Statistical evaluation of the composite clinical success scores confirmed the non-inferiority hypothesis. Revision was required in twenty-four patients in the resurfacing group and five patients in the total hip arthroplasty group. The most common cause of revision following resurfacing was failure of the femoral component (fracture of the femoral neck or loosening of the femoral component).nnnCONCLUSIONSnCareful review of this study population revealed several important criteria for successful introduction of this resurfacing device into the United States. These include careful patient selection based on clinical and radiographic parameters and attention to various surgical details of implantation. These findings can be used to focus the training process for surgeons who wish to add implantation of this device to their surgical armamentarium. Such efforts should help to ensure safe and effective introduction of this new technology.

Early Return to Function After Hip Resurfacing: Is It Better Than Contemporary Total Hip Arthroplasty?

Our hypothesis was that return of function for young patients undergoing resurfacing total hip arthroplasty (THA) with metal-on-metal bearings or contemporary THA with ceramic bearings would be comparable. Results from 337 unilateral hip resurfacing patients were compared with results from 266 unilateral ceramic-on-ceramic THA patients. Early differences in Harris Hip Scores were observed, but all differences faded by 24 months. Hip resurfacing seems to be a viable alternative to THA for well-selected patients. However, the public perception of improved functional capabilities was not demonstrated in this patient population. Resurfacing patients may be more impaired (slightly higher pain scores/lower function scores) than their THA counterparts in the early postoperative period, but these differences disappear by 24 months when both groups report Harris Hip Scores in the excellent range.

Making core decompression work

Meaningful assessment of a treatment modality for osteonecrosis (ON) must take into account a number of factors: (1) an accurate diagnosis, (2) consistent staging of the disease process, (3) understanding of the variability of the disease, (4) consistent application of the treatment modality (or the surgical technique), and (5) a clear understanding of the goal of the treatment used. This article reviews the important steps of a diagnostic algorithm that has been used to accurately diagnose and stage the disease process of ON. A consistent surgical technique with clearly defined goals is also outlined. The results of two clinical studies that were based on these diagnostic and therapeutic philosophies and that assess the role of core decompression in the treatment of ON are reviewed. The first study compared core decompression to conservative management in a prospective randomized study of 55 hips. Decompression provided more predictable pain relief and changed the indications for further surgical intervention more consistently than did conservative management. The second study represents a preliminary review of a ten-year study of the decompression procedure; it showed that core decompression was particularly useful in Stage I and Stage II ON. Roentgenographic stabilization was most predictable for Stage I hips. Core decompression can be a safe, effective, and predictable procedure in the treatment of Stage I and Stage II ON.

Multimodality approach to osteonecrosis of the femoral head.

Treatment of osteonecrosis of the femoral head appears to be effective when the disease is identified and treated early. Forty-one patients were evaluated with prospective laboratory assessment, anteroposterior and frog-lateral roentgenograms of both hips, intraosseous pressure measurements (IOP), magnetic resonance imaging (MRI), and 99mTc methylene diphosphonate planar and single-photon emission computerized tomographic (SPECT) bone imaging. Pathologic specimens were obtained in most patients. Preradiographic disease was identified in 26 hips and 11 of these were asymptomatic. Fifteen clinically symptomatic hips had normal plain roentgenograms, but abnormal protocol studies. Evaluation of sensitivity, specificity, and predictive value (positive and negative), respectively, in diagnosing osteonecrosis of the femoral head revealed the following percentages: 83%, 83%, 96%, and 48% for planar bone scanning; 91%, 78%, 94%, and 70% for SPECT; 87%, 83%, 96%, and 55% for MRI; 80%, 60%, 95%, and 25% for IOP; and 88%, 100%, 100%, and 25% for core biopsy. (There were few true negatives, thus specificity values are approximations.) The identification of preradiographic stages is possible, but difficult. MRI appears appealing at present, particularly in identifying disease in asymptomatic hips. However, there is no definitive method for noninvasive diagnosis. Pathologic confirmation in early stages is difficult.